Showing results (91-100 of 138) with videos related to

Sort By:
Pageof 14
Cellular and Molecular Gastroenterology and Hepatology|September 21, 2021
Gastric Organoids: Progress and Remaining ChallengesMin-Jiao Pang, Joseph R Burclaff, Ramon Jin, et al.
World Journal of Surgical Oncology|March 23, 2017
The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literatureYu-Ying Lei, Jin-Yu Huang, Qiong-Rui Zhao, et al.
Plos One|June 2, 2012
The association between individual SNPs or haplotypes of matrix metalloproteinase 1 and gastric cancer susceptibility, progression and prognosisYong-Xi Song, Xin Zhou, Zhen-Ning Wang, et al.
Cell Stem Cell|April 4, 2020
A Metformin-Responsive Metabolic Pathway Controls Distinct Steps in Gastric Progenitor Fate Decisions and MaturationZhi-Feng Miao, Mahliyah Adkins-Threats, Joseph R Burclaff, et al.
Gastroenterology|September 21, 2020
DDIT4 Licenses Only Healthy Cells to Proliferate During Injury-induced MetaplasiaZhi-Feng Miao, Jing-Xu Sun, Mahliyah Adkins-Threats, et al.
Molecular Cancer|January 6, 2011
MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferationYong-Xi Song, Zhen-Yu Yue, Zhen-Ning Wang, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 19, 2018
The efficacy and safety of targeted therapy with or without chemotherapy in advanced gastric cancer treatment: a network meta-analysis of well-designed randomized controlled trialsTing-Ting Zhao, Hao Xu, Hui-Mian Xu, et al.
BMC Cancer|February 2, 2018
Effect of neoadjuvant chemotherapy in patients with gastric cancer: a PRISMA-compliant systematic review and meta-analysisZhi-Feng Miao, Xing-Yu Liu, Zhen-Ning Wang, et al.
BMC Cancer|November 28, 2014
Which is the best postoperative chemotherapy regimen in patients with rectal cancer after neoadjuvant therapy?Peng Gao, Yong-xi Song, Jing-xu Sun, et al.
BMC Cancer|November 14, 2021
Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient dataJia-Yi Li, Xuan-Zhang Huang, Peng Gao, et al.
Pageof 14